tetano
Editor, Senior Moderator
Vaccines (Basel)
. 2021 Jun 2;9(6):588.
doi: 10.3390/vaccines9060588.
Comparison and Analysis of Neutralizing Antibody Levels in Serum after Inoculating with SARS-CoV-2, MERS-CoV, or SARS-CoV Vaccines in Humans
Sicong Yu[SUP] 1 2 [/SUP], Keda Chen[SUP] 3 [/SUP], Lei Fang[SUP] 2 [/SUP], Haiyan Mao[SUP] 2 [/SUP], Xiuyu Lou[SUP] 2 [/SUP], Chaonan Li[SUP] 3 [/SUP], Yanjun Zhang[SUP] 2 [/SUP]
Affiliations
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Middle East respiratory syndrome coronavirus (MERS-CoV), and severe acute respiratory syndrome coronavirus (SARS-CoV) pose a great threat to humanity. Every pandemic involving these coronaviruses has seriously affected human health and economic development. Currently, there are no approved therapeutic drugs against their infections. Therefore, the development of vaccines is particularly important to combat these coronaviruses. In this review, we summarized and analyzed the progress of vaccines against SARS-CoV, MERS-CoV, and SARS-CoV-2, including inactivated vaccines, live attenuated vaccines, subunit vaccines, nucleic acid vaccines, and viral vector vaccines. In addition, we compared the levels of neutralizing antibodies in the serum of patients with these three kinds of coronaviruses at different stages, and their ability and effects against SARS-CoV-2, MERS-CoV, and SARS-CoV. This review provides useful information for vaccine evaluation and analysis.
Keywords: MERS-CoV; SARS-CoV; SARS-CoV-2; neutralizing antibody; vaccine.
. 2021 Jun 2;9(6):588.
doi: 10.3390/vaccines9060588.
Comparison and Analysis of Neutralizing Antibody Levels in Serum after Inoculating with SARS-CoV-2, MERS-CoV, or SARS-CoV Vaccines in Humans
Sicong Yu[SUP] 1 2 [/SUP], Keda Chen[SUP] 3 [/SUP], Lei Fang[SUP] 2 [/SUP], Haiyan Mao[SUP] 2 [/SUP], Xiuyu Lou[SUP] 2 [/SUP], Chaonan Li[SUP] 3 [/SUP], Yanjun Zhang[SUP] 2 [/SUP]
Affiliations
- PMID: 34199384
- DOI: 10.3390/vaccines9060588
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Middle East respiratory syndrome coronavirus (MERS-CoV), and severe acute respiratory syndrome coronavirus (SARS-CoV) pose a great threat to humanity. Every pandemic involving these coronaviruses has seriously affected human health and economic development. Currently, there are no approved therapeutic drugs against their infections. Therefore, the development of vaccines is particularly important to combat these coronaviruses. In this review, we summarized and analyzed the progress of vaccines against SARS-CoV, MERS-CoV, and SARS-CoV-2, including inactivated vaccines, live attenuated vaccines, subunit vaccines, nucleic acid vaccines, and viral vector vaccines. In addition, we compared the levels of neutralizing antibodies in the serum of patients with these three kinds of coronaviruses at different stages, and their ability and effects against SARS-CoV-2, MERS-CoV, and SARS-CoV. This review provides useful information for vaccine evaluation and analysis.
Keywords: MERS-CoV; SARS-CoV; SARS-CoV-2; neutralizing antibody; vaccine.